Molecular recognition of p53 and MDM2 by USP7/HAUSP.

Sheng, Yi, Saridakis, Vivian, Sarkari, Feroz, Duan, Shili, Wu, Tianne, Arrowsmith, Cheryl H, Frappier, Lori·2006·Nature Structural & Molecular Biology
DOI 10.1038/nsmb1067

Cited by (316)

Items 301–316 of 316

  1. The disordered region 1 of Mdm2 weakens p53-binding in both its unmodified and hyperphospho-forms
    François‐Xavier Theillet, Yingyue Luo, Chafiaa Bouguechtouli, Jehanne Procaccia, Ania Alik, Magali Nicaise · 2026 · Research Square
  2. The molecular mechanisms regulating PAF15 chromatin association
    Ryota Miyashita · 2023 · Institutional Repositories DataBase (IRDB)
  3. Fonctions et régulations de la kinase CHK1 dans l'hématopoïèse normale et leucémique
    Maëlle Cartel · 2019 · theses.fr (ABES)
  4. Control, use and misuse of cellular signalling networks
    Pauline Juyoux · 2021 · theses.fr (ABES)
  5. Multidimensional analysis of deubiquitinating enzymes in colorectal cancer: biological mechanisms and targeted therapeutic strategies
    Ting Wang, Pingying Li, Shuo Xu, Guocai Xu · 2026 · Frontiers in Oncology
  6. Proteome-wide Ubiquitinome Profiling Reveals Substrate-specific Dynamics Within the USP7 Network
    Joyce Wolf van der Meer, Jan A. van der Knaap, Ayestha Sijm, Karel Bezstarosti, Dick H. W. Dekkers, Wouter A. S. Doff, Jeroen Demmers, C. Peter Verrijzer · 2026 · Molecular & Cellular Proteomics
  7. Targeting USP7 - a nano-therapeutic approach to restore and reactivate P53 for promoting apoptosis in glioma therapy
    S Vijay Kumar, Mrinal K. Ghosh · 2026 · Nanomedicine
  8. High-throughput screening identification of USP7 inhibitors reveals YM155 as a biologically active scaffold with in vivo antitumor efficacy
    Rita I. Oliveira, Caio Haddad Franco, Miguel Mano, Rahaf Habboub, David Eisenbarth, Ana S. Leal, Jorge A. R. Salvador · 2026 · Biomedicine & Pharmacotherapy
  9. Ubiquitination in cancer: mechanisms, signaling networks and potential therapeutic opportunities
    Yan Xue, Huiying Wu, Wu Liu · 2026 · Molecular Cancer
  10. TRIM25 facilitates mitochondrial dysfunction and extracellular matrix degradation by enhancing USP7‐driven ENO1 deubiquitination during intervertebral disc degeneration
    Xiaoming Liu, Wenyu Zhang, Hang Feng, Linying Lai, Chen Cao, Guang Yang, Yanzheng Gao, Bijun Wang, Hui Wang, Bin Yu et al. · 2026 · Clinical and Translational Medicine
  11. A Proximity-Driven Functional Screening Platform for the Discovery of Noninhibitory USP7 Ligand Enabling Targeted Protein Stabilization
    Kate E Young, Janitha Kumarathunga, Hiruni Kandambi, Vitoria Fernandes Ferro, Weijun Gui · 2026 · bioRxiv (Cold Spring Harbor Laboratory)
  12. Molecular mechanism of HUWE1-HAPSTR1-USP7-mediated ubiquitin chain amplification on nuclear proteins
    Stanislau Yatskevich, Jugal Mohapatra, Rana M Mroue, Lilian Phu, Alexander Leitner, Caleigh M. Azumaya, RICHARD L. VANDLEN, Tommy K. Cheung, Tik Hang Soong, Christopher M. Rose et al. · 2026 · Molecular Cell
  13. USP7 inhibits FOXO1 activity in chronic lymphocytic leukaemia cells enhancing cell survival
    Hassan N. B. Almuhanna, Jodie Hay, Michael W. Moles, Lucy Clarke, Jennifer E. Cassels, Alison Sefcick, Alison M. McCaig, Heather G. Jørgensen, Alison M. Michie · 2026 · Molecular Oncology
  14. BindingDB Entry 50018466: Recent advances in the development of ubiquitin-specific-processing protease 7 (USP7) inhibitors.
    BindingDB · 2024 · UC San Diego
  15. BindingDB Entry 50001159: Chemical Approaches to Intervening in Ubiquitin Specific Protease 7 (USP7) Function for Oncology and Immune Oncology Therapies.
    BindingDB · 2020 · UC San Diego
  16. Host Ubiquitin-Specific Proteases Regulate All Stages of Herpesvirus Infection
    Mohamed Maarouf, Christopher S. Peterson, Kareem N. Mohni · 2026 · International Journal of Molecular Sciences